Sandhya Mandlekar

4.9k citations
70 papers · 3.6k indexed · h-index 28

Sandhya Mandlekar

68 papers receiving 3.5k citations

Peers

Sandhya Mandlekar
Comparison fields: 5 of 124
  • Biochemistry 339
  • Pharmacology 432
  • Toxicology 143
  • Oncology 846
  • Molecular Biology 2.1k
Replace Shing‐Chuan Shen with:
Shing‐Chuan Shen Taiwan
Guoxiang Shen United States
Seong‐Su Han United States
Yen‐Chou Chen Taiwan
Dong‐Oh Moon South Korea
Byoung‐Mog Kwon South Korea
Tae Cheon Jeong South Korea
Gopalakrishnan Ramakrishnan United States
Mee‐Hyun Lee South Korea
Grace Chao Yeh United States
Sandhya Mandlekar relative to Shing‐Chuan Shen Taiwan Shing‐Chuan Shen's profile →
Citations per field
00.5×1.7×
Shing‐Chuan Shen · 1×
Citations per year

Countries citing papers authored by Sandhya Mandlekar

Since Specialization
Citations

This map shows the geographic impact of Sandhya Mandlekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandhya Mandlekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandhya Mandlekar more than expected).

Fields of papers citing papers by Sandhya Mandlekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandhya Mandlekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandhya Mandlekar. The network helps show where Sandhya Mandlekar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sandhya Mandlekar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sandhya Mandlekar Line = papers co-authored together Sandhya Mandlekar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 20222
3 20205
4 201813
5 20183
6 20164
7 2016147
8 201560
9 201516
10 201415
11 20136
12 201327
13 20092
14 200723
15 200656
16 2001137
17 2001270
18 2000175
19 199916
20 19988

About Sandhya Mandlekar

Sandhya Mandlekar is a scholar working on Pharmacology, Oncology and Toxicology, having authored 70 papers that have together received 3.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Genomics, phytochemicals, and oxidative stress (12 papers), Pharmacogenetics and Drug Metabolism (9 papers), HIV/AIDS drug development and treatment (8 papers), Chemokine receptors and signaling (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Synthesis and biological activity (6 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Biochemistry (339 citations), Pharmacology (432 citations) and Toxicology (143 citations). Sandhya Mandlekar has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Rong Yu, Angela Kong, Rong Yu, Ah‐Ng Tony Kong, Tse‐Hua Tan, Chi Chen, Vidya Hebbar, Lei Wei, Rong Yu and Edward D. Owuor. Their work appears in journals such as Journal of Medicinal Chemistry, Drug Metabolism and Disposition, Molecular Pharmacology, Bioanalysis and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026